Back to Trials
NCT01890486Recruiting

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Wake Forest University Health Sciences

Start Date

5/21/2001

Completion Date

12/1/2026

Summary

To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.

Detailed Description

To provide an IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant or cellular therapies for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach. To provide a consent mechanism for the retrospective study of cellular products, when available, if there is a specific question to be addressed.

Eligibility Criteria

Age Range: 18 years to 120 years

Inclusion Criteria: Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant Exclusion Criteria: Participation in any other treatment research protocol

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous LeukemiaNon-Hodgkin's LymphomaHodgkin's DiseaseMultiple MyelomaGerm Cell NeoplasmsMyelodysplastic SyndromesChronic Lymphocytic LeukemiaImmunodeficiency Diseases

Locations

Wake Forest Baptist Health

Winston-Salem, North Carolina 27157

United States